Smartlab Europe

News

Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality

Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the “Smart Manufacturing” transformation that is accelerating across the Pharma and Biotech industry. Aizon...

Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients

Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to support Rigel's ongoing Phase 3 clinical trial to evaluate...

Dubai launches Vaccine Logistics Alliance to boost global fight against pandemic

Dubai has launched a logistics alliance that aims to speed up distribution of Covid-19 vaccines around the world through the emirate. The Dubai Vaccines Logistics Alliance said it would combine Emirates SkyCargo’s air network with DP World’s worldwide network of...

Clariant launches natural VOC-trapping DESVOCANT adsorbents for packaging & cargo shipments

Welcome relief from VOCs: Clariant unveils an innovative line of new sustainably-mined clay mineral-based DESVOCANT adsorbents to efficiently reduce the potential exposure of shipment handlers, merchants, and consumers to volatile organic compounds (VOCs) from enclosed manufactured products. VOCs can accumulate...

Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstones Vaccine Platform Technology for HIV Cure

Gilead Sciences, Inc. and Gritstone Oncology, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the companies have entered into a collaboration, option and license agreement to research and develop a vaccine-based immunotherapy...

Lilly Partners with Area Health Systems to Help Enable Access to Important Antibody Infusion Therapies for COVID-19 Patients

Eli Lilly and Company has partnered with local health systems to launch dedicated infusion center locations serving central, northern, and now southern Indiana that are intended to provide Hoosiers with access to important COVID-19 treatments. Multiple neutralizing antibody therapies,...

Valneva Announces UK Government Exercise of Option for 40 Million Doses of its Inactivated, Adjuvanted COVID-19 Vaccine

Valneva SE , a specialty vaccine company focused on prevention against diseases with major unmet needs, reported that the UK Government has exercised its option to order 40 million doses of its inactivated, adjuvanted COVID-19 vaccine candidate for supply...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »